{"schema_version":"secwatch.filing_event.v1","accession":"0001793229-25-000106","form_type":"8-K","ticker":"CTEV","cik":"0001793229","company_name":"Claritev Corp","filed_at":"2025-05-08T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.741469+00:00","generated_at":"2026-05-22T05:10:30.789358+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Claritev Q1 revenue $231.3M (-1.4% YoY); net loss $71.3M vs $539.7M; reaffirms FY guidance","bullets":["Revenue $231.3M, down 1.4% from $234.5M; net loss improved to $71.3M from $539.7M.","Adjusted EBITDA $142.1M (61.4% margin) vs $146.8M in prior year.","Free cash flow negative $(68.9)M vs positive $19.2M; cash $23.1M.","Reaffirmed FY2025 guidance: revenue (2)% to flat, Adj. EBITDA margin 62.5%-63.5%, FCF $(65)-$(75)M.","Announced strategic alliances with Oracle, J2 Health, and Burjeel Holdings; new Chief Medical and AI officers."],"urls":{"canonical":"https://secwatch.observer/filing/0001793229-25-000106","json":"https://secwatch.observer/filing/0001793229-25-000106.json","markdown":"https://secwatch.observer/filing/0001793229-25-000106.md","text":"https://secwatch.observer/filing/0001793229-25-000106.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1793229/000179322925000106/0001793229-25-000106-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1793229/000179322925000106/ctev-20250508.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-22T05:10:30.789358+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}